Open original FDA record ↗Recall record
- FDA identifier
- Z-1243-2026
- Company in FDA record
- Focalyx Technologies, LLC.
- FDA classification date
- Feb 3, 2026
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Software device that is an accessory for image-guided interventional and diagnostic procedures involving prostate has accessories that may not function properly with Windows 10, which may cause patient harm during biopsy or cause treatment/therapy delays, so firm is recommending stop use until device is verified/validated with Windows 11.
Source facts
- Action
- On 12/23/2025, correction notices started being emailed to customers informing them of the following: You will be contacted to schedule installation of the new version. An IFU will be provided at time of installation. Complete and return the response form via email to corporate@focalyx.com If there are any questions, contact the firm at: focalyxtechnologies.com/contact, support@focalyxtechnologies.com, (888) 636 2259, (Sel. 3 Technical Support)
- Initiated
- 2025-12-23
- Root cause
- Software change control
- Distribution
- Worldwide - US Nationwide distribution in the states of NY, MA, FL and the countries of ES, VE, DO.
- Recall number
- Z-1243-2026
- Recall status
- Open, Classified
- CDRH record ID
- 217697
- FDA classified
- 2026-02-03
- Recall event number
- 98137